NASDAQ · Healthcare · Biotechnology
Damora Therapeutics, Inc.
DMRA
Damora Therapeutics, Inc. CEO Jennifer A. Jarrett · Market cap $1.3B.
$20.66
+0.42 · +2.08%
52w hi $38.3352w lo $4.95
Off 52w high 45.9%
59
ROUTINE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $50.00
Section 01
Recent Form 4 filings
1 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 25 | Jennifer Jarrett | Director, President and CEO | Buy | 12,500 | $20.23 | +$253K | 59 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct